ACADIA Pharmaceuticals Inc. vs Ross Stores, Inc. — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Ross Stores, Inc. trades at $252 (market cap $80.78B). The key difference: Ross Stores, Inc. is far larger — about 15.9× ACADIA Pharmaceuticals Inc.'s market cap, and Ross Stores, Inc. pays a 0.71% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | ROST | |
|---|---|---|
Market Cap | $5.07B | $80.78B |
Sector | Health | Consumer Cyclical |
52-Week High | $29.41 | $255.23 |
52-Week Low | $20.06 | $144.67 |
Enterprise Value | $4.19B | $81.37B |
Dividend Yield | — | 0.71% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →